[{"Assets_0_Q2_USD":1746363000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":51933000.0,"NetIncomeLoss_1_Q2_USD":50961000.0,"NetIncomeLoss_2_Q2_USD":86500000.0,"PaymentsOfDividendsCommonStock_2_Q2_USD":40091000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":56713000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":56430000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":55608000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":54807000.0,"StockholdersEquity_0_Q2_USD":803534000.0,"EarningsPerShareBasic_1_Q2_USD":0.92,"EarningsPerShareBasic_2_Q2_USD":1.58,"EarningsPerShareDiluted_1_Q2_USD":0.9,"EarningsPerShareDiluted_2_Q2_USD":1.53,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":704190000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":1320409000.0,"Ticker":"NUS","CIK":"1021561","name":"NU SKIN ENTERPRISES INC","OfficialName":"Nu Skin Enterprises Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2429332607.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"nan","filed":"20180803"}]